Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2019

Open Access 01-12-2019 | Hepatitis | Case report

Levothyroxine-induced liver injury followed by complete recovery upon cessation of the drug: a case report

Authors: Abbas F. Hlaihel, Mudher Z. H. Al-Khairalla

Published in: Journal of Medical Case Reports | Issue 1/2019

Login to get access

Abstract

Background

Levothyroxine is a synthetic thyroxine and is the treatment of choice for hypothyroidism. It is a prohormone with minimal intrinsic activity. The drug is de-iodinated in peripheral tissue to form triiodothyronine, which is the active thyroid hormone. On initiation of treatment, levothyroxine is titrated, and usually it is extremely well tolerated in the vast majority of patients. We report a case of a patient with self-limiting levothyroxine-induced liver injury, a rare adverse effect of this drug.

Case presentation

We report a case of a 34-year-old Mediterranean woman diagnosed with post-thyroidectomy hypothyroidism. She was commenced on levothyroxine and developed liver injury confirmed by noninvasive liver investigations. Complete recovery of the patient’s liver tests occurred upon cessation of the drug. Triiodothyronine was an appropriate treatment alternative.

Conclusion

Levothyroxine-induced liver injury is a rare, and in the present case report, a self-limiting, adverse effect. The diagnosis of our patient was confirmed via noninvasive diagnostic methods. Knowledge of this rare adverse effect is important in the differential diagnosis of patients who have commenced on levothyroxine and have deranged liver enzymes in the context of hypothyroidism.
Literature
1.
go back to reference Kawakami T, Tanaka A, Negoro S, et al. Liver injury induced by levothyroxine in a patient with primary hypothyroidism. Intern Med. 2007;46(14):1105–8.CrossRef Kawakami T, Tanaka A, Negoro S, et al. Liver injury induced by levothyroxine in a patient with primary hypothyroidism. Intern Med. 2007;46(14):1105–8.CrossRef
2.
go back to reference Ohmori M, Harada K, Tsuruoka S, et al. Levothyroxine-induced liver dysfunction in a primary hypothyroid patient. Endocr J. 1999;46(4):579–83.CrossRef Ohmori M, Harada K, Tsuruoka S, et al. Levothyroxine-induced liver dysfunction in a primary hypothyroid patient. Endocr J. 1999;46(4):579–83.CrossRef
3.
go back to reference Kang S, Amino N, Kudo T, et al. Occurrence of thyroxine tablet (Thyradin S®)–induced liver dysfunction in a patient with subclinical hypothyroidism. Endocr J. 2015;62(8):719–24.CrossRef Kang S, Amino N, Kudo T, et al. Occurrence of thyroxine tablet (Thyradin S®)–induced liver dysfunction in a patient with subclinical hypothyroidism. Endocr J. 2015;62(8):719–24.CrossRef
4.
go back to reference Chang CY, Schiano TD. Review article: drug hepatotoxicity. Aliment Pharmacol Ther. 2007;25:1135.CrossRef Chang CY, Schiano TD. Review article: drug hepatotoxicity. Aliment Pharmacol Ther. 2007;25:1135.CrossRef
5.
go back to reference Björnsson E, Talwalkar J, Treeprasertsuk S, Kamath PS, Takahashi N, Sanderson S, Neuhauser M, Lindor K. Drug-induced autoimmune hepatitis: clinical characteristics and prognosis. Hepatology. 2010;51(6):2040–8.CrossRef Björnsson E, Talwalkar J, Treeprasertsuk S, Kamath PS, Takahashi N, Sanderson S, Neuhauser M, Lindor K. Drug-induced autoimmune hepatitis: clinical characteristics and prognosis. Hepatology. 2010;51(6):2040–8.CrossRef
Metadata
Title
Levothyroxine-induced liver injury followed by complete recovery upon cessation of the drug: a case report
Authors
Abbas F. Hlaihel
Mudher Z. H. Al-Khairalla
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2019
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-019-2244-z

Other articles of this Issue 1/2019

Journal of Medical Case Reports 1/2019 Go to the issue